Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
AstraZeneca Wins Funding In England For First & Second Line Leukemia Drug
Calquence Will Provide A Chemo-Free Treatment Option for CLL
Mar 18 2021
•
By
Neena Brizmohun
NICE says Calquence is cost-effective • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Health Technology Assessment
More from Market Access